STARTUP NEWS EVENTS CALENDAR
These events are imported from Meetup and Eventbrite group pages. Please check the links for up-to-date details.
To see an overview of all major events of the year, go to the ‘WA Innovation Calendar 2003 – YEAR OVERVIEW’
Our monthly breakfast series is an opportunity for representatives from across the MTP sector to connect, collaborate and learn about upcoming opportunities, and hear the stories and successes of WA organisations developing health and medical innovations. Join us over a light breakfast in the last week of each month at the Harry Perkins Institute of Medical Research.
NeuroScientific Biopharmaceuticals Ltd (ASX:NSB) is an Australian drug development company developing novel peptide-based pharmaceutical products that target a number of neurological degenerative conditions with high unmet medical need, such as Alzheimer’s disease, Multiple Sclerosis and diseases of the optic nerve.
Dr Alexandra Heaton – Director of Operations, NeuroScientific Biopharmaceuticals Ltd (NSB)
Dr Heaton holds a PhD in Neuroscience from the University of Western Australia with her research concentrated on enhancing neuroplasticity and cognition in children.
Alexandra’s role at NSB covers operational logistics, product manufacturing, investor relations and corporate development.
Prior to joining NSB, Alexandra led US Business Development at Linear Clinical Research focusing on attracting partnerships with US biotechnology and pharmaceutical companies and coordinating early phase trials start-ups. She also has experience as a biotech co-founder.
Dr Heaton will discuss the company’s vision to improve the understanding and treatment of neurodegenerative disease, future opportunities for the biopharmaceuticals industry in WA, and take questions from the audience.
For any queries, please get in touch with Dr Tracey Wilkinson at [email protected].
If you’d like to have your WA startup event automatically displaying on this calendar, please email [email protected] your Meetup or Eventbrite group/events page links.
Sign up our newsletter to get update information, news and free insight.
